Breaking News

WuXi XDC, Celltrion Ink MOU for ADC Services

WuXi XDC to provide services from process development to GMP manufacturing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi XDC, a global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADCs and the other types of bioconjugates, and Celltrion, Inc., a global biopharmaceutical company, have signed a Memorandum of Understanding (MOU) for comprehensive and integrated services for the development and manufacturing of bioconjugates include antibody-drug conjugates (ADCs).   WuXi XDC will serve as primary service provider on each of the integrated projects, from process development t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters